Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kufner

Showing results (241-250 of 370) with videos related to

Pageof 37
Sort By:
JACC. Cardiovascular Interventions|October 30, 2023
Recurrent Revascularization at 10 Years After Percutaneous Treatment of Drug-Eluting Stent RestenosisTobias Koch, Tobias Lenz, Tobias Rheude, et al.
American Heart Journal|June 23, 2007
Sex and effect of abciximab in patients with acute coronary syndromes treated with percutaneous coronary interventions: results from Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment 2 trialJulinda Mehilli, Gjin Ndrepepa, Adnan Kastrati, et al.
Stroke|February 21, 2018
Hyperintense Vessels, Collateralization, and Functional Outcome in Patients With Stroke Receiving Endovascular TreatmentAlexander H Nave, Anna Kufner, Philipp Bücke, et al.
European Heart Journal|February 22, 2023
Coronary artery restenosis treatment with plain balloon, drug-coated balloon, or drug-eluting stent: 10-year outcomes of the ISAR-DESIRE 3 trialDaniele Giacoppo, Hector A Alvarez-Covarrubias, Tobias Koch, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 28, 2020
Antithrombotic therapy with or without clopidogrel after transcatheter aortic valve replacement. A meta-analysis of randomized controlled trialsCostanza Pellegrini, Erion Xhepa, Gjin Ndrepepa, et al.
Frontiers in Physiology|August 3, 2023
Dark-field X-ray imaging for the assessment of osteoporosis in human lumbar spine specimensFlorian T Gassert, Theresa Urban, Alexander Kufner, et al.
Journal of the American Heart Association|June 2, 2021
Ten-Year Clinical Outcomes of Biodegradable Versus Durable Polymer New-Generation Drug-Eluting Stent in Patients With Coronary Artery Disease With and Without Diabetes MellitusTobias Lenz, Tobias Koch, Michael Joner, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 6, 2016
Five-year follow-up of polymer-free sirolimus- and probucol-eluting stents versus new generation zotarolimus-eluting stents in patients presenting with st-elevation myocardial infarctionRoisin Colleran, Sebastian Kufner, Yukinori Harada, et al.
European Heart Journal. Cardiovascular Imaging|January 5, 2018
Vascular response to percutaneous coronary intervention with biodegradable-polymer vs. new-generation durable-polymer drug-eluting stents: a meta-analysis of optical coherence tomography imaging trialsSalvatore Cassese, Erion Xhepa, Gjin Ndrepepa, et al.
Journal of the American College of Cardiology|November 26, 2016
High-Sensitivity Troponin T and Mortality After Elective Percutaneous Coronary InterventionGjin Ndrepepa, Roisin Colleran, Siegmund Braun, et al.
Pageof 37

Showing results (241-250 of 370) with videos related to

Sort By:
Pageof 37
JACC. Cardiovascular Interventions|October 30, 2023
Recurrent Revascularization at 10 Years After Percutaneous Treatment of Drug-Eluting Stent RestenosisTobias Koch, Tobias Lenz, Tobias Rheude, et al.
American Heart Journal|June 23, 2007
Sex and effect of abciximab in patients with acute coronary syndromes treated with percutaneous coronary interventions: results from Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment 2 trialJulinda Mehilli, Gjin Ndrepepa, Adnan Kastrati, et al.
Stroke|February 21, 2018
Hyperintense Vessels, Collateralization, and Functional Outcome in Patients With Stroke Receiving Endovascular TreatmentAlexander H Nave, Anna Kufner, Philipp Bücke, et al.
European Heart Journal|February 22, 2023
Coronary artery restenosis treatment with plain balloon, drug-coated balloon, or drug-eluting stent: 10-year outcomes of the ISAR-DESIRE 3 trialDaniele Giacoppo, Hector A Alvarez-Covarrubias, Tobias Koch, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 28, 2020
Antithrombotic therapy with or without clopidogrel after transcatheter aortic valve replacement. A meta-analysis of randomized controlled trialsCostanza Pellegrini, Erion Xhepa, Gjin Ndrepepa, et al.
Frontiers in Physiology|August 3, 2023
Dark-field X-ray imaging for the assessment of osteoporosis in human lumbar spine specimensFlorian T Gassert, Theresa Urban, Alexander Kufner, et al.
Journal of the American Heart Association|June 2, 2021
Ten-Year Clinical Outcomes of Biodegradable Versus Durable Polymer New-Generation Drug-Eluting Stent in Patients With Coronary Artery Disease With and Without Diabetes MellitusTobias Lenz, Tobias Koch, Michael Joner, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 6, 2016
Five-year follow-up of polymer-free sirolimus- and probucol-eluting stents versus new generation zotarolimus-eluting stents in patients presenting with st-elevation myocardial infarctionRoisin Colleran, Sebastian Kufner, Yukinori Harada, et al.
European Heart Journal. Cardiovascular Imaging|January 5, 2018
Vascular response to percutaneous coronary intervention with biodegradable-polymer vs. new-generation durable-polymer drug-eluting stents: a meta-analysis of optical coherence tomography imaging trialsSalvatore Cassese, Erion Xhepa, Gjin Ndrepepa, et al.
Journal of the American College of Cardiology|November 26, 2016
High-Sensitivity Troponin T and Mortality After Elective Percutaneous Coronary InterventionGjin Ndrepepa, Roisin Colleran, Siegmund Braun, et al.
Pageof 37